Antifosfolipidsyndrom og graviditet

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Antifosfolipidsyndrom og graviditet. / Schreiber, Karen; Lykke, Jacob Alexander; Langhoff-Roos, Jens; Nielsen, Henriette Svarre; Jacobsen, Søren.

I: Ugeskrift for Laeger, Bind 178, Nr. 12, V09150730, 01.2016, s. 2-5.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Schreiber, K, Lykke, JA, Langhoff-Roos, J, Nielsen, HS & Jacobsen, S 2016, 'Antifosfolipidsyndrom og graviditet', Ugeskrift for Laeger, bind 178, nr. 12, V09150730, s. 2-5.

APA

Schreiber, K., Lykke, J. A., Langhoff-Roos, J., Nielsen, H. S., & Jacobsen, S. (2016). Antifosfolipidsyndrom og graviditet. Ugeskrift for Laeger, 178(12), 2-5. [V09150730].

Vancouver

Schreiber K, Lykke JA, Langhoff-Roos J, Nielsen HS, Jacobsen S. Antifosfolipidsyndrom og graviditet. Ugeskrift for Laeger. 2016 jan.;178(12):2-5. V09150730.

Author

Schreiber, Karen ; Lykke, Jacob Alexander ; Langhoff-Roos, Jens ; Nielsen, Henriette Svarre ; Jacobsen, Søren. / Antifosfolipidsyndrom og graviditet. I: Ugeskrift for Laeger. 2016 ; Bind 178, Nr. 12. s. 2-5.

Bibtex

@article{f3a75f0b776b48028a7d5caf465ab8a6,
title = "Antifosfolipidsyndrom og graviditet",
abstract = "Antiphospholipid syndrome (APS) is the association of antiphospholipid antibodies with thromboses and/or obstetric morbidity. Obstetric morbidity includes recurrent first trimester loss, stillbirth, intrauterine death, preeclam-psia, premature birth and fetal growth restriction. Although current treatment regimens including aspirin and low-molecular weight heparin have improved pregnancy outcomes, 30% of affected women have pregnancy complica-tions. Women with APS are therefore high-risk pregnancies who should be monitored in specialist centres according to international standards.",
keywords = "English Abstract, Journal Article",
author = "Karen Schreiber and Lykke, {Jacob Alexander} and Jens Langhoff-Roos and Nielsen, {Henriette Svarre} and S{\o}ren Jacobsen",
year = "2016",
month = jan,
language = "Dansk",
volume = "178",
pages = "2--5",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "12",

}

RIS

TY - JOUR

T1 - Antifosfolipidsyndrom og graviditet

AU - Schreiber, Karen

AU - Lykke, Jacob Alexander

AU - Langhoff-Roos, Jens

AU - Nielsen, Henriette Svarre

AU - Jacobsen, Søren

PY - 2016/1

Y1 - 2016/1

N2 - Antiphospholipid syndrome (APS) is the association of antiphospholipid antibodies with thromboses and/or obstetric morbidity. Obstetric morbidity includes recurrent first trimester loss, stillbirth, intrauterine death, preeclam-psia, premature birth and fetal growth restriction. Although current treatment regimens including aspirin and low-molecular weight heparin have improved pregnancy outcomes, 30% of affected women have pregnancy complica-tions. Women with APS are therefore high-risk pregnancies who should be monitored in specialist centres according to international standards.

AB - Antiphospholipid syndrome (APS) is the association of antiphospholipid antibodies with thromboses and/or obstetric morbidity. Obstetric morbidity includes recurrent first trimester loss, stillbirth, intrauterine death, preeclam-psia, premature birth and fetal growth restriction. Although current treatment regimens including aspirin and low-molecular weight heparin have improved pregnancy outcomes, 30% of affected women have pregnancy complica-tions. Women with APS are therefore high-risk pregnancies who should be monitored in specialist centres according to international standards.

KW - English Abstract

KW - Journal Article

M3 - Tidsskriftartikel

C2 - 26815583

VL - 178

SP - 2

EP - 5

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 12

M1 - V09150730

ER -

ID: 180942106